These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 2991322)

  • 21. Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception.
    Kekkonen R; Lähteenmäki P; Luukkainen T; Tuominen J
    Fertil Steril; 1993 Oct; 60(4):610-5. PubMed ID: 8405512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mode of action of RU 486.
    Bygdeman M; Swahn ML; Gemzell-Danielsson K; Svalander P
    Ann Med; 1993 Feb; 25(1):61-4. PubMed ID: 8435191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of progesterone receptor blockade in the luteal phase of normal fertile women.
    Li TC; Dockery P; Thomas P; Rogers AW; Lenton EA; Cooke ID
    Fertil Steril; 1988 Nov; 50(5):732-42. PubMed ID: 3181485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy.
    Batista MC; Cartledge TP; Zellmer AW; Merino MJ; Axiotis C; Loriaux DL; Nieman LK
    Am J Obstet Gynecol; 1992 Jul; 167(1):60-5. PubMed ID: 1442957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gonadotropin, estrogen and progesterone response to long term gonadotropin-releasing hormone infusion at various stages of the menstrual cycle.
    Jewelewicz R; Dyrenfurth I; Ferin M; Bogumil J; Vande Wiele RL
    J Clin Endocrinol Metab; 1977 Oct; 45(4):662-7. PubMed ID: 334788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mechanism of LH release with synthetic LH-RH (author's transl)].
    Koyama T
    Nihon Naibunpi Gakkai Zasshi; 1976 Sep; 52(9):881-97. PubMed ID: 828583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of levonorgestrel administered in large doses at different stages of the cycle on ovarian function and endometrial morphology.
    Landgren BM; Johannisson E; Aedo AR; Kumar A; Shi YE
    Contraception; 1989 Mar; 39(3):275-89. PubMed ID: 2496951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The antiprogesterone steroid RU-486 does not impair gonadotropin-stimulated luteal adenylyl cyclase activity or gonadotropin release by pituitary cells.
    Rojas FJ; O'Conner JL; Asch RH
    J Steroid Biochem; 1985 Dec; 23(6A):1053-8. PubMed ID: 3937946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
    Katkam RR; Gopalkrishnan K; Chwalisz K; Schillinger E; Puri CP
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):779-87. PubMed ID: 7573244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of a sequential regimen of mifepristone-medroxyprogesterone acetate on ovarian function, endometrial development and hormonal parameters.
    Croxatto HB; Massai MR; Salvatierra AM; Fuentealba B; Croxatto HD; Lähteenmäki P
    Contraception; 1996 Aug; 54(2):79-86. PubMed ID: 8842583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of menstruation by an antiprogesterone steroid (RU 486) in primates: site of action, dose-response relationships, and hormonal effects.
    Healy DL; Baulieu EE; Hodgen GD
    Fertil Steril; 1983 Aug; 40(2):253-7. PubMed ID: 6307760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of daily low dose mifepristone on the ovarian cycle and on dynamics of follicle growth.
    Cameron ST; Thong KJ; Baird DT
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):407-14. PubMed ID: 7586613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to intermittent RU486 in women.
    Spitz IM; Croxatto HB; Salvatierra AM; Heikinheimo O
    Fertil Steril; 1993 May; 59(5):971-5. PubMed ID: 8486197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
    Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
    J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Why does RU486 fail to prevent implantation despite success in inducing menstruation?
    Li TC; Lenton EA; Dockery P; Rogers AW; Cooke ID
    Contraception; 1988 Oct; 38(4):401-6. PubMed ID: 3208514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the antiprogesterone RU 486 in normal women. I. Single-dose administration in the midluteal phase.
    Shoupe D; Mishell DR; Lahteenmaki P; Heikinheimo O; Birgerson L; Madkour H; Spitz IM
    Am J Obstet Gynecol; 1987 Dec; 157(6):1415-20. PubMed ID: 2827481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Termination of early pregnancy by the progesterone antagonist RU 486 (Mifepristone).
    Couzinet B; Le Strat N; Ulmann A; Baulieu EE; Schaison G
    N Engl J Med; 1986 Dec; 315(25):1565-70. PubMed ID: 3785321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postpartum return of ovarian activity in nonbreastfeeding women monitored by urinary assays.
    Gray RH; Campbell OM; Zacur HA; Labbok MH; MacRae SL
    J Clin Endocrinol Metab; 1987 Apr; 64(4):645-50. PubMed ID: 3818896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pituitary-ovarian function after tubal ligation.
    Alvarez-Sanchez F; Segal SJ; Brache V; Adejuwon CA; Leon P; Faundes A
    Fertil Steril; 1981 Nov; 36(5):606-9. PubMed ID: 7308505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The rhesus monkey corpus luteum is dependent on pituitary gonadotropin secretion throughout the luteal phase of the menstrual cycle.
    Hutchison JS; Zeleznik AJ
    Endocrinology; 1984 Nov; 115(5):1780-6. PubMed ID: 6436009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.